Free Trial

Ardelyx (ARDX) Stock Forecast & Price Target

Ardelyx logo
$5.67 -0.02 (-0.35%)
(As of 11/29/2024 05:27 PM ET)

Ardelyx - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
6

Based on 8 Wall Street analysts who have issued ratings for Ardelyx in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 2 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for ARDX.

Consensus Price Target

$10.42
83.72% Upside
According to the 8 analysts' twelve-month price targets for Ardelyx, the average price target is $10.42. The highest price target for ARDX is $15.00, while the lowest price target for ARDX is $5.50. The average price target represents a forecasted upside of 83.72% from the current price of $5.67.
Get the Latest News and Ratings for ARDX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ardelyx and its competitors.

Sign Up

ARDX Analyst Ratings Over Time

TypeCurrent Forecast
12/1/23 to 11/30/24
1 Month Ago
11/1/23 to 10/31/24
3 Months Ago
9/2/23 to 9/1/24
1 Year Ago
12/1/22 to 12/1/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.42$11.67$11.67$9.10
Forecasted Upside83.72% Upside98.75% Upside88.78% Upside91.18% Upside
Consensus Rating
Moderate Buy
Buy
Buy
Buy

ARDX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ARDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ardelyx Stock vs. The Competition

TypeArdelyxMedical CompaniesS&P 500
Consensus Rating Score
2.88
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside83.72% Upside25,353.14% Upside6.50% Upside
News Sentiment Rating
Positive News

See Recent ARDX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/11/2024HC Wainwright
2 of 5 stars
E. Arce
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$11.00 ➝ $5.50+8.48%
11/4/2024Citigroup
3 of 5 stars
 Lower TargetBuy ➝ Buy$12.00 ➝ $10.00+73.01%
8/2/2024Wedbush
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$11.00 ➝ $11.00+94.69%
7/2/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Raymond
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$15.00 ➝ $7.00+28.91%
6/20/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
4/5/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Ruiz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/5/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$14.00+95.53%
1/9/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$12.00 ➝ $15.00+83.37%
8/3/2023LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$7.50 ➝ $8.50+110.40%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:49 AM ET.


ARDX Forecast - Frequently Asked Questions

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Ardelyx is $10.42, with a high forecast of $15.00 and a low forecast of $5.50.

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ardelyx in the last twelve months. There are currently 2 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ARDX shares.

According to analysts, Ardelyx's stock has a predicted upside of 83.72% based on their 12-month stock forecasts.

Over the previous 90 days, Ardelyx's stock had 1 downgrade by analysts.

Ardelyx has been rated by research analysts at Citigroup, and HC Wainwright in the past 90 days.

Analysts like Ardelyx more than other "medical" companies. The consensus rating score for Ardelyx is 2.88 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ARDX compares to other companies.


This page (NASDAQ:ARDX) was last updated on 11/30/2024 by MarketBeat.com Staff
From Our Partners